Authors:
BERRY G
BILLINGHAM M
ALDERMAN E
RICHARDSON P
TORTI F
LUM B
PATEK A
MARTIN FJ
Citation: G. Berry et al., THE USE OF CARDIAC BIOPSY TO DEMONSTRATE REDUCED CARDIOTOXICITY IN AIDS-KAPOSIS SARCOMA PATIENTS TREATED WITH PEGYLATED LIPOSOMAL DOXORUBICIN, Annals of oncology, 9(7), 1998, pp. 711-716
Authors:
ADVANI R
SABA HI
TALLMAN M
ROWE JM
WIERNIK PH
RAMEK J
DUGAN K
LUM B
VILLENA J
SIKIC BI
DAVIS E
PAIETTA E
LITCHMAN M
GREENBERG P
Citation: R. Advani et al., TREATMENT OF POOR-PROGNOSIS AML WITH PSC833 PLUS MITOXANTRONE, ETOPOSIDE, CYTARABINE (PSC-MEC), Blood, 90(10), 1997, pp. 2260-2260
Authors:
GOSLAND M
LUM B
SCHIMMELPFENNIG J
BAKER J
DOUKAS M
Citation: M. Gosland et al., INSIGHTS INTO MECHANISMS OF CISPLATIN RESISTANCE AND POTENTIAL FOR ITS CLINICAL REVERSAL, Pharmacotherapy, 16(1), 1996, pp. 16-39
Authors:
MOCHON M
COONEY G
LUM B
CAPUTO GC
DUNN S
GOLDSMITH B
BALUARTE HJ
POLINSKY MS
KAISER BA
Citation: M. Mochon et al., PHARMACOKINETICS OF CYCLOSPORINE AFTER RENAL-TRANSPLANT IN CHILDREN, Journal of clinical pharmacology, 36(7), 1996, pp. 580-586
Authors:
ADVANI R
SABA H
ROWE JM
TALLMAN M
WIERNIK P
RAMEK J
DUGAN K
LITCHMAN M
DORR R
LUM B
SIKIC B
DAVIS E
PAIETTA E
GREENBERG P
Citation: R. Advani et al., TREATMENT OF REFRACTORY RELAPSED AML WITH PSC833 PLUS MITOXANTRONE, ETOPOSIDE, CYTARABINE (PSC-MEC)/, Blood, 88(10), 1996, pp. 847-847